The Epilepsy Therapy Project of the Epilepsy Foundation accelerates ideas into therapies for people living with epilepsy and seizures.
More than a third of the more than 2 million people living with epilepsy in the United States have persistent seizures using existing therapies. Many others tolerate serious side effects, including diminished cognition, as a price for seizure control. New therapies introduced over the last decade offer fewer side effects but have done little to bring effective seizure control to the significant population living with active and uncontrolled epilepsy. Despite this serious unmet medical need, research funding for epilepsy is scarce and existing philanthropic support limited. Further, many major pharmaceutical companies have scaled back epilepsy development programs. As a result, successful lab research and new findings are rarely translated into new epilepsy therapy.
The Epilepsy Foundation works to overcome the barriers to successful translation of promising new research insights and to make new therapies a reality for patients. We provide financial support and scientific and business direction to promising new therapies, and we invest in programs and platforms that can take time and costs out of new therapy development.